PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
22-May-2019 CO.DON AG: Capital increase completed successfully CO.DON AG
22-May-2019 Interstitial Lung Disease (ILD) Experts And Advocates Announce Formation Of Open Source Imaging Consortium (OSIC) Open Source Imaging Consortium (OSIC)
22-May-2019 Abacus Medicine sets price range for planned Initial Public Offering between EUR 14.50 to EUR 16.00 per share (news with additional features) Abacus Medicine A/S
22-May-2019 PAION AG: ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS AND ELECTS DR. LEYCK DIEKEN TO THE SUPERVISORY BOARD PAION AG
22-May-2019 Orphan Drugs Market to Reach US$ 294000 Mn by 2025, Increasing Development of Oncology-related Orphan Drugs to Drive the Market: Fortune Business Insights Fortune Business Insights
22-May-2019 Alkermes to Present New Data From Mental Health Portfolio at the American Society of Clinical Psychopharmacology 2019 Annual Meeting Alkermes plc
22-May-2019 West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards West Pharmaceutical Services, Inc.
22-May-2019 FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis Mayne Pharma
22-May-2019 Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement Halozyme Therapeutics, Inc.
22-May-2019 Probiodrug to attend International Conferences in June 2019 Probiodrug AG
22-May-2019 Insmed Announces Pricing of Public Offering of Common Stock Insmed Incorporated
21-May-2019 Mallinckrodt Announces Election of Carlos V. Paya, M.D., Ph.D. to its Board of Directors Mallinckrodt plc
21-May-2019 Agendia and Imegen Announce an Exclusive Distribution Agreement for MammaPrint® and BluePrint® in Spain and Portugal B3C newswire
21-May-2019 Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions Eli Lilly & Company
21-May-2019 Digital Therapeutic Innovator NightWare Granted "Breakthrough Status" by U.S. Food and Drug Administration NightWare
21-May-2019 Noridian Posts Favorable Draft Local Coverage Determination for Natera's Prospera(TM) Kidney Transplant Test Natera
21-May-2019 Rapid Nutrition Announces Appointment of Doug Kuskopf-Dallas as Vice President of Sales Rapid Nutrition PLC
21-May-2019 Heidelberg Pharma AG Reports Outcome Of Annual General Meeting Heidelberg Pharma AG
21-May-2019 WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement WuXi STA
21-May-2019 LifeArc monetises Keytruda® (pembrolizumab) royalty interests to fund further research and investment LifeArc